Erratum to "CPAP treatment in obstructive sleep apnoea: A randomised, controlled trial of follow-up with a focus on patient satisfaction" [Sleep Medicine 10 (2009) 869-874] (DOI:10.1016/j.sleep.2008.08.008);CPAP treatment in obstructive sleep apnoea: A randomised, controlled trial of follow-up with a focus on patient satisfaction

Sleep Medicine

Volumn 10, Issue 8, 2009, Pages 869-874

  Holmdahl, C ^a,c   Schollin I L ^a   Alton, M ^a   Nilsson, K ^b,c  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c CAMTÖ Centre for Assessment of Medical Technology in Örebro   (Sweden)

Author keywords

CPAP; Follow up; Obstructive sleep apnoea syndrome; Patient satisfaction; Quality of life; Specialist nurse

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; OUTCOME ASSESSMENT; OXIMETRY; OXYGEN SATURATION; PATIENT SATISFACTION; PHYSICIAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

EID: 68749118369     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.10.001     Document Type: Erratum

References (33)

1. Gibson G.J. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull 72 (2004) 49-65
2. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
3. Lindberg E., and Gislason T. Clinical review article: epidemiology of sleep-related obstructive breathing. Sleep Med Rev 4 (2000) 411-433
4. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 (2005) 2034-2041
5. Marti S., Sampol G., Munoz X., Torres F., Roca A., Lloberes P., et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 20 (2002) 1511-1518
6. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., De la Cruz-Moron I., Perez-Ronchel J., De la Vega-Gallardo F., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128 (2005) 624-633
7. Gami A.S., Caples S.M., and Somers V.K. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32 (2003) 869-894
8. Laitinen L.A., Anttalainen U., Pietinalho A., Hamalainen P., and Koskela K. Sleep apnoea: finnish national guidelines for prevention and treatment 2002-2012. Respir Med 97 (2003) 337-365
9. Giles T.L., Lasserson T.J., Smith B.H., White J., Wright J., and Cates C.J. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 3 (2006) CD001106
10. Parish J.M., and Lyng P.J. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest 124 (2003) 942-947
11. Liistro G., Aubert G., and Rodenstein D.O. Management of sleep apnoea syndrome. Eur Respir J 8 (1995) 1751-1755
12. Kawahara S., Akashiba T., Akahoshi T., and Horie T. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern Med 44 (2005) 422-427
13. American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med 1994; 150: 1738-1745.
14. Meslier N., Lebrun T., Grillier-Lanoir V., Rolland N., Henderick C., Sailly J.C., et al. A French survey of 3, 225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 12 (1998) 185-192
15. Pelletier-Fleury N., Meslier N., Gagnadoux F., Person C., Rakotonanahary D., Ouksel H., et al. Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur Respir J 23 (2004) 53-60
16. Albarrak M., Banno K., Sabbagh A.A., Delaive K., Walld R., Manfreda J., et al. Utilization of healthcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP. Sleep 28 (2005) 1306-1311
17. Tarasiuk A., Greenberg-Dotan S., Brin Y.S., Simon T., Tal A., and Reuveni H. Determinants affecting health care utilization in obstructive sleep apnea syndrome patients. Chest 128 (2005) 1310-1314
18. Ayas N.T., FitzGerald J.M., Fleetham J.A., White D.P., Schulzer M., Ryan C.F., et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 166 (2006) 977-984
19. Pepin J.L., Krieger J., Rodenstein D., Cornette A., Sforza E., Delguste P., et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 160 (1999) 1124-1129
20. McNicholas W.T. Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough?. Eur Respir J 10 (1997) 969-970
21. Helgesen F., Andersson S.O., Gustafsson O., Varenhorst E., Goben B., Carnock S., et al. Follow-up of prostate cancer patients by on-demand contacts with a specialist nurse: a randomized study. Scand J Urol Nephrol 34 (2000) 55-61
22. Raftery J.P., Yao G.L., Murchie P., Campbell N.C., and Ritchie L.D. Cost-effectiveness of nurse-led secondary prevention clinics for coronary heart disease in primary care: follow-up of a randomised controlled trial. BMJ 330 (2005) 707
23. Ryan P. The benefits of a nurse-led preoperative assessment clinic. Nurs Times 96 (2000) 42-43
24. Bolton L.B., Aydin C.E., Donaldson N., Brown D.S., Nelson M.S., and Harms D. Nurse staffing and patient perceptions of nursing care. J Nurs Adm 33 (2003) 607-614
25. Sullivan M., Karlsson J., and Ware Jr. J.E. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 41 (1995) 1349-1358
26. Hoy C.J., Vennelle M., Kingshott R.N., Engleman H.M., and Douglas N.J. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?. Am J Respir Crit Care Med 159 (1999) 1096-1100
27. Palmer S., Selvaraj S., Dunn C., Osman L.M., Cairns J., Franklin D., et al. Annual review of patients with sleep apnea/hypopnea syndrome-a pragmatic randomised trial of nurse home visit versus consultant clinic review. Sleep Med 5 (2004) 61-65
28. Tomlinson M., and John Gibson G. Obstructive sleep apnoea syndrome: a nurse-led domiciliary service. J Adv Nurs 55 (2006) 391-397
29. Vrijhoef H.J., Diederiks J.P., and Spreeuwenberg C. Effects on quality of care for patients with NIDDM or COPD when the specialised nurse has a central role: a literature review. Patient Educ Couns 41 (2000) 243-250
30. Thompson D.R., Quinn T., and Stewart S. Effective nurse-led interventions in heart disease. Int J Cardiol 83 (2002) 233-237
31. Flemons W.W., Littner M.R., Rowley J.A., Gay P., Anderson W.M., Hudgel D.W., et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review cosponsored by theAmerican Academy of Sleep Medicine, the American College of Chest Physicians and the American Thoracic Society. Chest 124 (2003) 1543-1579
32. Franklin K,Rehnqvist N, Axelsson S. Obstructive sleep apnoea syndrome. A systematic litterture review.SBU,Sweden 2007.ISBN 978-91-85413-16-4.
33. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545